Global Recombinant Proteins Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 11/23/2022
- NO OF PAGES
- 238
- CATEGORY
- Healthcare & Life Sciences
The competitive landscape analysis of Recombinant Proteins Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Recombinant Proteins Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Recombinant Proteins Market: Top Key Players
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Recombinant Proteins Breakdown Data by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
Recombinant Proteins Breakdown Data by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
Global Recombinant Proteins Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Recombinant Proteins Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Recombinant Proteins Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.
Market Segmentations:
Global Recombinant Proteins Market: Top Key Players
Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation
Recombinant Proteins Breakdown Data by Type
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.
Recombinant Proteins Breakdown Data by Application
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.
Global Recombinant Proteins Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Reasons to Purchase Recombinant Proteins Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Proteins Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Hormones
1.4.3 Growth Factors
1.4.4 Cytokines
1.4.5 Plasma Protein Factor
1.4.6 Recombinant Metabolic Enzymes
1.4.7 Immune Checkpoint Regulators
1.4.8 Others
1.5 Market by Application
1.5.1 Global Recombinant Proteins Market Share by Application: 2022 VS 2030
1.5.2 Biopharmaceutical Companies
1.5.3 Academic and Research Institutes
1.5.4 Contract Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Proteins Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Proteins Industry
1.6.1.1 Recombinant Proteins Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Proteins Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Proteins Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Recombinant Proteins Market Perspective (2016-2030)
2.2 Recombinant Proteins Growth Trends by Regions
2.2.1 Recombinant Proteins Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Recombinant Proteins Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Proteins Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant Proteins Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Proteins Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Market Size
3.1.1 Global Top Recombinant Proteins Players by Revenue (2016-2021)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2016-2021)
3.1.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Proteins Market Concentration Ratio
3.2.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2021
3.3 Recombinant Proteins Key Players Head office and Area Served
3.4 Key Players Recombinant Proteins Product Solution and Service
3.5 Date of Enter into Recombinant Proteins Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Recombinant Proteins Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2022-2030)
5 Recombinant Proteins Breakdown Data by Application (2016-2030)
5.1 Global Recombinant Proteins Market Size by Application (2016-2021)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Recombinant Proteins Market Size (2016-2021)
6.2 Recombinant Proteins Key Players in North America (2016-2021)
6.3 North America Recombinant Proteins Market Size by Type (2016-2021)
6.4 North America Recombinant Proteins Market Size by Application (2016-2021)
7 Europe
7.1 Europe Recombinant Proteins Market Size (2016-2021)
7.2 Recombinant Proteins Key Players in Europe (2016-2021)
7.3 Europe Recombinant Proteins Market Size by Type (2016-2021)
7.4 Europe Recombinant Proteins Market Size by Application (2016-2021)
8 China
8.1 China Recombinant Proteins Market Size (2016-2021)
8.2 Recombinant Proteins Key Players in China (2016-2021)
8.3 China Recombinant Proteins Market Size by Type (2016-2021)
8.4 China Recombinant Proteins Market Size by Application (2016-2021)
9 Japan
9.1 Japan Recombinant Proteins Market Size (2016-2021)
9.2 Recombinant Proteins Key Players in Japan (2016-2021)
9.3 Japan Recombinant Proteins Market Size by Type (2016-2021)
9.4 Japan Recombinant Proteins Market Size by Application (2016-2021)
10 Middle East
10.1 Middle East Recombinant Proteins Market Size (2016-2021)
10.2 Recombinant Proteins Key Players in Middle East (2016-2021)
10.3 Middle East Recombinant Proteins Market Size by Type (2016-2021)
10.4 Middle East Recombinant Proteins Market Size by Application (2016-2021)
11 India
11.1 India Recombinant Proteins Market Size (2016-2021)
11.2 Recombinant Proteins Key Players in India (2016-2021)
11.3 India Recombinant Proteins Market Size by Type (2016-2021)
11.4 India Recombinant Proteins Market Size by Application (2016-2021)
12 Central & South America
12.1 Central & South America Recombinant Proteins Market Size (2016-2021)
12.2 Recombinant Proteins Key Players in Central & South America (2016-2021)
12.3 Central & South America Recombinant Proteins Market Size by Type (2016-2021)
12.4 Central & South America Recombinant Proteins Market Size by Application (2016-2021)
13 Key Players Profiles
13.1 Abcam PLC
13.1.1 Abcam PLC Company Details
13.1.2 Abcam PLC Business Overview and Its Total Revenue
13.1.3 Abcam PLC Recombinant Proteins Introduction
13.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2016-2021)
13.1.5 Abcam PLC Recent Development
13.2 R&D Systems
13.2.1 R&D Systems Company Details
13.2.2 R&D Systems Business Overview and Its Total Revenue
13.2.3 R&D Systems Recombinant Proteins Introduction
13.2.4 R&D Systems Revenue in Recombinant Proteins Business (2016-2021)
13.2.5 R&D Systems Recent Development
13.3 Miltenyi Biotec
13.3.1 Miltenyi Biotec Company Details
13.3.2 Miltenyi Biotec Business Overview and Its Total Revenue
13.3.3 Miltenyi Biotec Recombinant Proteins Introduction
13.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021)
13.3.5 Miltenyi Biotec Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction
13.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Sigma Aldrich Company
13.5.1 Sigma Aldrich Company Company Details
13.5.2 Sigma Aldrich Company Business Overview and Its Total Revenue
13.5.3 Sigma Aldrich Company Recombinant Proteins Introduction
13.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021)
13.5.5 Sigma Aldrich Company Recent Development
13.6 GE Healthcare
13.6.1 GE Healthcare Company Details
13.6.2 GE Healthcare Business Overview and Its Total Revenue
13.6.3 GE Healthcare Recombinant Proteins Introduction
13.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2016-2021)
13.6.5 GE Healthcare Recent Development
13.7 Lonza
13.7.1 Lonza Company Details
13.7.2 Lonza Business Overview and Its Total Revenue
13.7.3 Lonza Recombinant Proteins Introduction
13.7.4 Lonza Revenue in Recombinant Proteins Business (2016-2021)
13.7.5 Lonza Recent Development
13.8 Merck KGaA
13.8.1 Merck KGaA Company Details
13.8.2 Merck KGaA Business Overview and Its Total Revenue
13.8.3 Merck KGaA Recombinant Proteins Introduction
13.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2016-2021)
13.8.5 Merck KGaA Recent Development
13.9 ProSpec Tany TechnoGene
13.9.1 ProSpec Tany TechnoGene Company Details
13.9.2 ProSpec Tany TechnoGene Business Overview and Its Total Revenue
13.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
13.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021)
13.9.5 ProSpec Tany TechnoGene Recent Development
13.10 Eurogentec (Kaneka Corporation)
13.10.1 Eurogentec (Kaneka Corporation) Company Details
13.10.2 Eurogentec (Kaneka Corporation) Business Overview and Its Total Revenue
13.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction
13.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021)
13.10.5 Eurogentec (Kaneka Corporation) Recent Development
13.11 PeproTech
10.11.1 PeproTech Company Details
10.11.2 PeproTech Business Overview and Its Total Revenue
10.11.3 PeproTech Recombinant Proteins Introduction
10.11.4 PeproTech Revenue in Recombinant Proteins Business (2016-2021)
10.11.5 PeproTech Recent Development
13.12 BPS Bioscience
10.12.1 BPS Bioscience Company Details
10.12.2 BPS Bioscience Business Overview and Its Total Revenue
10.12.3 BPS Bioscience Recombinant Proteins Introduction
10.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021)
10.12.5 BPS Bioscience Recent Development
13.13 Reprocell
10.13.1 Reprocell Company Details
10.13.2 Reprocell Business Overview and Its Total Revenue
10.13.3 Reprocell Recombinant Proteins Introduction
10.13.4 Reprocell Revenue in Recombinant Proteins Business (2016-2021)
10.13.5 Reprocell Recent Development
13.14 GenScript Biotech Corporation
10.14.1 GenScript Biotech Corporation Company Details
10.14.2 GenScript Biotech Corporation Business Overview and Its Total Revenue
10.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction
10.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021)
10.14.5 GenScript Biotech Corporation Recent Development
13.15 Abnova Corporation
10.15.1 Abnova Corporation Company Details
10.15.2 Abnova Corporation Business Overview and Its Total Revenue
10.15.3 Abnova Corporation Recombinant Proteins Introduction
10.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021)
10.15.5 Abnova Corporation Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Proteins Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Hormones
1.4.3 Growth Factors
1.4.4 Cytokines
1.4.5 Plasma Protein Factor
1.4.6 Recombinant Metabolic Enzymes
1.4.7 Immune Checkpoint Regulators
1.4.8 Others
1.5 Market by Application
1.5.1 Global Recombinant Proteins Market Share by Application: 2022 VS 2030
1.5.2 Biopharmaceutical Companies
1.5.3 Academic and Research Institutes
1.5.4 Contract Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Proteins Industry Impact
1.6.1 How the Covid-19 is Affecting the Recombinant Proteins Industry
1.6.1.1 Recombinant Proteins Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Recombinant Proteins Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Recombinant Proteins Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Recombinant Proteins Market Perspective (2016-2030)
2.2 Recombinant Proteins Growth Trends by Regions
2.2.1 Recombinant Proteins Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Recombinant Proteins Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Proteins Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Recombinant Proteins Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Proteins Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Proteins Players by Market Size
3.1.1 Global Top Recombinant Proteins Players by Revenue (2016-2021)
3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2016-2021)
3.1.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Proteins Market Concentration Ratio
3.2.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2021
3.3 Recombinant Proteins Key Players Head office and Area Served
3.4 Key Players Recombinant Proteins Product Solution and Service
3.5 Date of Enter into Recombinant Proteins Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2030)
4.1 Global Recombinant Proteins Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Proteins Forecasted Market Size by Type (2022-2030)
5 Recombinant Proteins Breakdown Data by Application (2016-2030)
5.1 Global Recombinant Proteins Market Size by Application (2016-2021)
5.2 Global Recombinant Proteins Forecasted Market Size by Application (2022-2030)
6 North America
6.1 North America Recombinant Proteins Market Size (2016-2021)
6.2 Recombinant Proteins Key Players in North America (2016-2021)
6.3 North America Recombinant Proteins Market Size by Type (2016-2021)
6.4 North America Recombinant Proteins Market Size by Application (2016-2021)
7 Europe
7.1 Europe Recombinant Proteins Market Size (2016-2021)
7.2 Recombinant Proteins Key Players in Europe (2016-2021)
7.3 Europe Recombinant Proteins Market Size by Type (2016-2021)
7.4 Europe Recombinant Proteins Market Size by Application (2016-2021)
8 China
8.1 China Recombinant Proteins Market Size (2016-2021)
8.2 Recombinant Proteins Key Players in China (2016-2021)
8.3 China Recombinant Proteins Market Size by Type (2016-2021)
8.4 China Recombinant Proteins Market Size by Application (2016-2021)
9 Japan
9.1 Japan Recombinant Proteins Market Size (2016-2021)
9.2 Recombinant Proteins Key Players in Japan (2016-2021)
9.3 Japan Recombinant Proteins Market Size by Type (2016-2021)
9.4 Japan Recombinant Proteins Market Size by Application (2016-2021)
10 Middle East
10.1 Middle East Recombinant Proteins Market Size (2016-2021)
10.2 Recombinant Proteins Key Players in Middle East (2016-2021)
10.3 Middle East Recombinant Proteins Market Size by Type (2016-2021)
10.4 Middle East Recombinant Proteins Market Size by Application (2016-2021)
11 India
11.1 India Recombinant Proteins Market Size (2016-2021)
11.2 Recombinant Proteins Key Players in India (2016-2021)
11.3 India Recombinant Proteins Market Size by Type (2016-2021)
11.4 India Recombinant Proteins Market Size by Application (2016-2021)
12 Central & South America
12.1 Central & South America Recombinant Proteins Market Size (2016-2021)
12.2 Recombinant Proteins Key Players in Central & South America (2016-2021)
12.3 Central & South America Recombinant Proteins Market Size by Type (2016-2021)
12.4 Central & South America Recombinant Proteins Market Size by Application (2016-2021)
13 Key Players Profiles
13.1 Abcam PLC
13.1.1 Abcam PLC Company Details
13.1.2 Abcam PLC Business Overview and Its Total Revenue
13.1.3 Abcam PLC Recombinant Proteins Introduction
13.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2016-2021)
13.1.5 Abcam PLC Recent Development
13.2 R&D Systems
13.2.1 R&D Systems Company Details
13.2.2 R&D Systems Business Overview and Its Total Revenue
13.2.3 R&D Systems Recombinant Proteins Introduction
13.2.4 R&D Systems Revenue in Recombinant Proteins Business (2016-2021)
13.2.5 R&D Systems Recent Development
13.3 Miltenyi Biotec
13.3.1 Miltenyi Biotec Company Details
13.3.2 Miltenyi Biotec Business Overview and Its Total Revenue
13.3.3 Miltenyi Biotec Recombinant Proteins Introduction
13.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2016-2021)
13.3.5 Miltenyi Biotec Recent Development
13.4 Thermo Fisher Scientific
13.4.1 Thermo Fisher Scientific Company Details
13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction
13.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2016-2021)
13.4.5 Thermo Fisher Scientific Recent Development
13.5 Sigma Aldrich Company
13.5.1 Sigma Aldrich Company Company Details
13.5.2 Sigma Aldrich Company Business Overview and Its Total Revenue
13.5.3 Sigma Aldrich Company Recombinant Proteins Introduction
13.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2016-2021)
13.5.5 Sigma Aldrich Company Recent Development
13.6 GE Healthcare
13.6.1 GE Healthcare Company Details
13.6.2 GE Healthcare Business Overview and Its Total Revenue
13.6.3 GE Healthcare Recombinant Proteins Introduction
13.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2016-2021)
13.6.5 GE Healthcare Recent Development
13.7 Lonza
13.7.1 Lonza Company Details
13.7.2 Lonza Business Overview and Its Total Revenue
13.7.3 Lonza Recombinant Proteins Introduction
13.7.4 Lonza Revenue in Recombinant Proteins Business (2016-2021)
13.7.5 Lonza Recent Development
13.8 Merck KGaA
13.8.1 Merck KGaA Company Details
13.8.2 Merck KGaA Business Overview and Its Total Revenue
13.8.3 Merck KGaA Recombinant Proteins Introduction
13.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2016-2021)
13.8.5 Merck KGaA Recent Development
13.9 ProSpec Tany TechnoGene
13.9.1 ProSpec Tany TechnoGene Company Details
13.9.2 ProSpec Tany TechnoGene Business Overview and Its Total Revenue
13.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction
13.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2016-2021)
13.9.5 ProSpec Tany TechnoGene Recent Development
13.10 Eurogentec (Kaneka Corporation)
13.10.1 Eurogentec (Kaneka Corporation) Company Details
13.10.2 Eurogentec (Kaneka Corporation) Business Overview and Its Total Revenue
13.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction
13.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2016-2021)
13.10.5 Eurogentec (Kaneka Corporation) Recent Development
13.11 PeproTech
10.11.1 PeproTech Company Details
10.11.2 PeproTech Business Overview and Its Total Revenue
10.11.3 PeproTech Recombinant Proteins Introduction
10.11.4 PeproTech Revenue in Recombinant Proteins Business (2016-2021)
10.11.5 PeproTech Recent Development
13.12 BPS Bioscience
10.12.1 BPS Bioscience Company Details
10.12.2 BPS Bioscience Business Overview and Its Total Revenue
10.12.3 BPS Bioscience Recombinant Proteins Introduction
10.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2016-2021)
10.12.5 BPS Bioscience Recent Development
13.13 Reprocell
10.13.1 Reprocell Company Details
10.13.2 Reprocell Business Overview and Its Total Revenue
10.13.3 Reprocell Recombinant Proteins Introduction
10.13.4 Reprocell Revenue in Recombinant Proteins Business (2016-2021)
10.13.5 Reprocell Recent Development
13.14 GenScript Biotech Corporation
10.14.1 GenScript Biotech Corporation Company Details
10.14.2 GenScript Biotech Corporation Business Overview and Its Total Revenue
10.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction
10.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2016-2021)
10.14.5 GenScript Biotech Corporation Recent Development
13.15 Abnova Corporation
10.15.1 Abnova Corporation Company Details
10.15.2 Abnova Corporation Business Overview and Its Total Revenue
10.15.3 Abnova Corporation Recombinant Proteins Introduction
10.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2016-2021)
10.15.5 Abnova Corporation Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Pricing
Select a license type that suits your business needs
Single User Access
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
Multi User Cost
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
Enterprise User Cost
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI